Sign In
Buy GOSS
$0.188
-0.0119 (-5.94%)
At Close: Jun 03, 2026
NEW YORK, June 02, 2020 -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Gossamer Bio, Inc. (NASDAQ: GOSS) (i) pursuant and/or.
The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of GOSS, GSX and BIDU
10:20am, Tuesday, 02'nd Jun 2020
NEW YORK, NY / ACCESSWIRE / June 2, 2020 / The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. There is no cost to participa
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Gossamer Bio, Inc. - GOSS
03:45am, Tuesday, 02'nd Jun 2020
NEW YORK, NY / ACCESSWIRE / June 1, 2020 / Pomerantz LLP is investigating claims on behalf of investors Gossamer Bio, Inc. ("Gossamer" or the "Company") (NASDAQ:GOSS). Such investors ...
SHAREHOLDER ALERT: GOSS R SRNE: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines
10:10pm, Monday, 01'st Jun 2020
NEW YORK, NY / ACCESSWIRE / June 1, 2020 / The Law Offices of Vincent Wong announce that class actions have commenced on behalf of certain shareholders in the following companies. If you suffered a lo
Investors who purchased the Company's securities pursuant and/or traceable to the Company's initial public offering in February 2019 (the "IPO" ) or between February 8, 2019 and December 13, 2019, inc
New York, New York--(Newsfile Corp. - June 1, 2020) - Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against Gossamer Bio, Inc. ("Gossamer " or "the Co
New York, New York--(Newsfile Corp. - June 1, 2020) - The following statement is being issued by Levi & Korsinsky, LLP:To: All persons or entities who purchased or otherwise acquired securities of Gos
Los Angeles, California--(Newsfile Corp. - June 1, 2020) - The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Gossamer Bio, Inc.
Gossamer Bio Announces Participation in Upcoming Investor Conferences
11:35am, Monday, 01'st Jun 2020
Gossamer Bio, Inc. (Nasdaq: GOSS), a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing and commercializing therapeutics in the disease areas of immunology, inflamm
The Gross Law Firm Announces Class Actions on Behalf of Shareholders of GOSS, GSX and IQ
10:20am, Monday, 01'st Jun 2020
NEW YORK, NY / ACCESSWIRE / June 1, 2020 / The securities litigation law firm of The Gross Law Firm issues the following notice on behalf of shareholders in the following publicly traded companies. Sh
Investors who purchased the Company's securities pursuant and/or traceable to the Company's initial public offering in February 2019 (the "IPO" ) or between February 8, 2019 and December 13, 2019, inc
NEW YORK, NY / ACCESSWIRE / May 31, 2020 / Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against Gossamer Bio, Inc. ("Gossamer " or "the ...
Los Angeles, California--(Newsfile Corp. - May 31, 2020) - The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Gossamer Bio, Inc.
NEW YORK, NY / ACCESSWIRE / May 30, 2020 / Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Gossamer Bio, Inc. (NASDAQ:GOSS) (i) pursuant and/or traceable to
Investors who purchased the Company's securities pursuant and/or traceable to the Company's initial public offering in February 2019 (the "IPO" ) or between February 8, 2019 and December 13, 2019, inc
